Your browser doesn't support javascript.
loading
Developmental arrest in Drosophila melanogaster caused by mitochondrial DNA replication defects cannot be rescued by the alternative oxidase.
Rodrigues, Ana Paula C; Camargo, André F; Andjelkovic, Ana; Jacobs, Howard T; Oliveira, Marcos T.
Afiliação
  • Rodrigues APC; Departamento de Tecnologia, Faculdade de Ciências Agrárias e Veterinárias, Universidade Estadual Paulista "Júlio de Mesquita Filho", 14884-900, Jaboticabal, SP, Brazil.
  • Camargo AF; Departamento de Tecnologia, Faculdade de Ciências Agrárias e Veterinárias, Universidade Estadual Paulista "Júlio de Mesquita Filho", 14884-900, Jaboticabal, SP, Brazil.
  • Andjelkovic A; Faculty of Medicine and Life Sciences and Tampere University Hospital, University of Tampere, Tampere, FI-33014, Finland.
  • Jacobs HT; Institute of Biotechnology, University of Helsinki, Helsinki, FI-00014, Finland.
  • Oliveira MT; Faculty of Medicine and Life Sciences and Tampere University Hospital, University of Tampere, Tampere, FI-33014, Finland.
Sci Rep ; 8(1): 10882, 2018 Jul 18.
Article em En | MEDLINE | ID: mdl-30022066
The xenotopic expression of the alternative oxidase AOX from the tunicate Ciona intestinalis in diverse models of human disease partially alleviates the phenotypic effects of mitochondrial respiratory chain defects. AOX is a non-proton pumping, mitochondrial inner membrane-bound, single-subunit enzyme that can bypass electron transport through the cytochrome segment, providing an additional site for ubiquinone reoxidation and oxygen reduction upon respiratory chain overload. We set out to investigate whether AOX expression in Drosophila could counteract the effects of mitochondrial DNA (mtDNA) replication defects caused by disturbances in the mtDNA helicase or DNA polymerase γ. We observed that the developmental arrest imposed by either the expression of mutant forms of these enzymes or their knockdown was not rescued by AOX. Considering also the inability of AOX to ameliorate the phenotype of tko25t, a fly mutant with mitochondrial translation deficiency, we infer that this alternative enzyme may not be applicable to cases of mitochondrial gene expression defects. Finding the limitations of AOX applicability will help establish the parameters for the future putative use of this enzyme in gene therapies for human mitochondrial diseases.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxirredutases / Proteínas de Plantas / DNA Mitocondrial / Doenças Mitocondriais / Proteínas de Drosophila / Proteínas Mitocondriais / Replicação do DNA / Drosophila melanogaster / Mitocôndrias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxirredutases / Proteínas de Plantas / DNA Mitocondrial / Doenças Mitocondriais / Proteínas de Drosophila / Proteínas Mitocondriais / Replicação do DNA / Drosophila melanogaster / Mitocôndrias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido